If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this ...

This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...

THURSDAY, Oct. 30, 2025 (HealthDay News) -- Two mechanisms of structural and functional retinal impairment based on papilledema severity have been identified among patients with idiopathic ...

THURSDAY, Oct. 30, 2025 (HealthDay News) — Doctors think they’ve figured out a way to predict who might lose vision due to a high brain pressure disorder. Idiopathic intracranial hypertension (IIH) ...

The optic disc is a non-sensory spot in the retina where the axons of the ganglion cells carrying afferent light-induced impulses to the visual cortex of the brain converge to leave the eye. It ...

For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional ...

IIH is most common in obese women of reproductive age but can affect anyone. A 5–10% reduction in body weight can significantly reduce intracranial pressure. Acetazolamide and topiramate are the main ...

Papilledema is a serious medical condition where the optic nerve at the back of the eye becomes swollen. Symptoms can include visual disturbances, headaches, and nausea. Papilledema occurs when there ...